The Boston Semaglutide and Tirzepatide Weight Loss Program is a great way to safely lose weight and keep it off.
If you’re really trying to lose those extra pounds and nothing works, you might be feeling a bit frustrated. You have perfect assistance at the gym, you make the effort to run a few miles every week, you watch what you eat, and you are generally a healthy person. But still, those extra pounds are there.
Fortunately, there are promising new medical advancements that offer a potential solution to these challenges. Semaglutide in 2021 and Tirzepatide in 2022 were granted approval as groundbreaking weight-loss medications. This was a significant development because Semaglutide and Tirzepatide are the first weight loss medications to receive FDA approval in 14 years and have proven to be the most effective to date!
Let’s dive into everything you need to know about these groundbreaking weight loss medications:
What is Semaglutide and Tirzepatide?
Semaglutide and Tirzapitide are pharmaceuticals belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class of drugs, which exerts its effects on the brain, pancreas, and gastrointestinal system to enhance feelings of fullness and regulate the absorption of food.
Historically, Semaglutide and Tirzepatide were administered to individuals with type-2 diabetes to enhance their management of blood sugar levels. Numerous clinical investigations have demonstrated Semaglutide and Tirzepatide’s efficacy as a weight loss treatment. Of course, Semaglutide and Tirzepatide works best for keeping weight in check when combined with changes in diet and regular exercise.
Patients can anticipate the following benefits:
Semaglutide + BPC-157 a weight loss game changer.
FDA approved glucagon-like peptide Studies have demonstrated that Semaglutide reduces appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control.
BPC-157 stands for Body Protection Compound 157, a peptide chain. It helps decrease intestinal damage and inflammation. (AKA leaky gut)
How It Works
After meeting the medical team and going over details specific to the patient’s medical history to confirm eligibility for the program, the patient will start with a low dose of Semaglutide or Tirzepatide which will increase with time.
Typically, individuals using Semaglutide or Tirzepatide experience a weight reduction of approximately 15% of their total body weight. Research and studies indicate that this non-surgical weight loss medication is effective in helping patients reach their goals. However, it needs a dedicated commitment of time and discipline.
Part of the treatment regimen includes regular appointments with a medical specialist who will oversee the process. During these appointments, the specialist will address your health status and weight loss progress.
Semaglutide and Tirzepatide are administered using an insulin syringe. A professional will provide instructions on how to self-administer these injections.The patient will only need to do this once a week. Once the patient achieved their goal, a decreased dosage schedule will be provided.
If you’re aiming to lose weight, Semaglutide and Tizepatide could play a role in achieving your weight goals.
We at Sound Shapes are here to address your queries and guide you in making the appropriate decisions to steer you toward better health and overall well-being.
‘A Game Changer’: Drug Brings Weight Loss in Patients With Obesity
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average. Those who got the drug lost close to 15 percent of their body weight, on average, compared with 2.4 percent among those receiving a placebo. And it is expected that patients would have to take it for a lifetime to prevent the weight loss from coming back.
— The New York Times 10/26/21, 10:23 AM Semaglutide Brings Significant Weight Loss in Obese Patients
Two versions of Semaglutide and Tripeptide have been approved by the FDA: one designed for the treatment of type 2 diabetes and another for weight management.
The weight management program generally employs a slightly elevated dosage to achieve its intended results. It is not intended for individuals seeking to shed just a few pounds; rather, it is reserved for those who are medically categorized as overweight or obese.
Only patients who have been medically classified as overweight (with a BMI of 27 or more) or obese (with a BMI of 30 or more) can be eligible for Semaglutide and Tirzepitide.
Eligibility criteria include individuals with type 2 diabetes or those with uncontrolled A1C levels. Furthermore, eligibility extends to individuals with a diagnosis of high cholesterol or high blood pressure in conjunction with the specified BMI. Additionally, certain patients with heart failure or kidney disease may also qualify.
However, if there is a personal or family history of other thyroid or endocrine cancers, this may render you ineligible to participate in a semaglutide weight loss program.
Similar to most medical treatments, Semaglutide and Tirzepitide can lead to common side effects, typically of a non-serious nature.
These side effects can include low blood sugar, constipation, fatigue, headache, abdominal pain, nausea, vomiting, diarrhea, dizziness, and acid reflux.
For the majority of patients, these symptoms tend to be mild and typically resolve on their own. However, if they persist, we offer medications for relief. You can reduce the likelihood of experiencing these side effects by:
Frequently Asked Questions
The speed of weight loss varies per patient. Some patients may notice the effects after the initial dose, whereas others may need more sessions and time to start seeing changes.
Several clinical trials have shown that patients receiving a 2.4 mg dose lost a mean of 6% of their weight after three months. After six months, most patients in a cohort study lost 5–10% of their weight. Some even lost 20% or more.
This can be achieved if the patients combine the injections with a healthy diet and daily exercise. The effectiveness of reducing belly fat may vary from person to person. Results depend on factors like age, sex, genetics, and lifestyle habits.
Semaglutide and Tirzepatide injections are a type of medicine that falls under the group of incretin mimetics. These injections help the pancreas release the right amount of insulin when your blood sugar is too high. Insulin then helps move sugar from your blood into different parts of your body where it can be used for energy.
Semaglutide and Tirzepatide don’t function like common over-the-counter fat burners.
By being a weight loss medication that increases metabolism, Semaglutide and Tirzepitide helps the body burn more calories and fat faster, leading to weight loss.
The studies on Semaglutide and Tirzepitide for weight loss tell us that many people who stop taking the medication gain the weight back within a year. That’s why it’s really important to stick to the treatment plan and live a healthy lifestyle to make sure you keep the weight off in the long run.
As mentioned above, the typical side effects of Semaglutide and Tirzepitide are nausea, vomiting, and diarrhea. Although uncommon, there is a possibility of severe side effects, like allergic reactions. If you have any worries about the risks or side effects of this medication, please discuss them with your healthcare provider during a consultation.
Not everyone qualifies for Semaglutide and Tirzepatide. As previously mentioned, doctors can recommend this medication for adults who are experiencing obesity, with a body mass index (BMI) exceeding 30, or for those who are overweight, with a BMI over 27, and who have health problems linked to their weight, such as high blood pressure, type 2 diabetes, or high cholesterol.